4 companies to watch in the accelerating gene editing race
PharmaVoice
JANUARY 2, 2025
A handful of innovative startups are scrambling to gain a foothold as technology improves at a rapid clip.
PharmaVoice
JANUARY 2, 2025
A handful of innovative startups are scrambling to gain a foothold as technology improves at a rapid clip.
STAT
JANUARY 2, 2025
The new year ushered in a final slate of updates to the federal rules for how hospitals have to disclose their prices, and experts are optimistic the changes will make the data more helpful in identifying less expensive providers. The updates are fairly straightforward. The government is requiring hospitals to include additional pieces of data to improve their consistency and make it easier to compare across hospitals.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
JANUARY 2, 2025
New chemotherapy-free treatment shows promise for EGFR-mutated NSCLC
Express Pharma
JANUARY 2, 2025
The type 1 diabetes (T1D) market across the seven major markets (7MM*) is set to grow at a compound annual growth rate (CAGR) of 13.3 per cent from $2.2 billion in 2023 to $9.9 billion in 2033, driven by the anticipated introduction of several late-stage pipeline products, including multiple immunomodulatory agents, during the forecast period, according to GlobalData.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Dive
JANUARY 2, 2025
Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology sector regain its footing after a shaky year.
The Pharmacist
JANUARY 2, 2025
More than 50 pharmacies have closed in the last three years despite being given despite special protection funding from the government under the Pharmacy Access Scheme. This represents 4% of the 1,444 pharmacies eligible to claim funding under the scheme set up to 'capture the pharmacies that are most important for patient access, those […] The post More than 50 Access Scheme pharmacies have closed since 2022, NPA claims appeared first on The Pharmacist.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Pharmacist
JANUARY 2, 2025
Supermarket Morrisons has today launched an online private prescription service, called Morrisons Clinic. The clinic has been launched in partnership with digital pharmacy Phlo. It offers a range of services including treatment for acid reflux, acne, erectile dysfunction, menopause, and contraceptive and weight loss services. In a statement released today, Morrisons said that customers in […] The post Morrisons launches online private prescription service with Phlo appeared first on The Ph
pharmaphorum
JANUARY 2, 2025
Early cancer diagnoses have risen to record levels in England, says NHS, but long waiting times for treatment threaten to undermine the gains.
The Pharmacist
JANUARY 2, 2025
A community pharmacist and the chief executive of medicines trade body PAGB have been recognised in the King's New Year Honours list for 2025. Alan Malcom Kurtz, proprietor and manager of Fishers Chemist in Croydon, South London, was awarded a British Empire Medal (BME) for his services to community pharmacy. The medal is awarded to […] The post New Year Honours for community pharmacist and PAGB chief appeared first on The Pharmacist.
pharmaphorum
JANUARY 2, 2025
The first of three phase 3 trials of Neumora's novel antidepressant navacaprant has ended in failure, wreaking havoc with its share price
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
PharmaTech
JANUARY 2, 2025
The guidance provides recommendations for those interested in participating in FDAs Advanced Manufacturing Technologies Designation Program.
pharmaphorum
JANUARY 2, 2025
Roche licenses rights to a DLL3-targeted ADC from China's Innovent, hoping to bring a competitor to Amgen's lung cancer therapy Imdelltra to market
BioPharma Dive
JANUARY 2, 2025
The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results as a “worst-case scenario for the program.
pharmaphorum
JANUARY 2, 2025
Valo Health will no longer develop its ROCK1/2 inhibitor for diabetic retinopathy on its own after a trial readout but will seek to partner the drug
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
PharmaTech
JANUARY 2, 2025
The company is recalling one lot of PROGRAF 0.5mg (tacrolimus) and one lot of ASTAGRAF XL 0.5mg (tacrolimus extended-release) capsules because some bottles may contain empty capsules.
pharmaphorum
JANUARY 2, 2025
Hutchmed has agreed to divest its share of a non-core Chinese JV through a pair of deals that will give it a cash injection to plough into R&D.
Pharmaceutical Technology
JANUARY 2, 2025
Effective management of atopic dermatitis (AD) has been one of the top priorities for physicians over the years, as quality of life in these patients is compromised due to the disruptive symptoms that they experience, which include itchiness and skin inflammation.
BioPharma Dive
JANUARY 2, 2025
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end of recent annual tallies.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmaceutical Technology
JANUARY 2, 2025
Eli Lilly and Novo Nordisk have been competing in the obesity market for the past year, making it an opportune time to review the benefits of the two most prominent obesity medications.
BioPharma Dive
JANUARY 2, 2025
Sangamo shares fell on Pfizer’s decision to hand back rights to a hemophilia gene therapy. Elsewhere, Novartis got long-awaited data and BioNTech settled with the NIH.
Pharmaceutical Technology
JANUARY 2, 2025
Explore how strategic intelligence agencies and competitive intelligence solutions are shaping the pharmaceutical industry. Download our guide to technological advancements and more invaluable industry insights.
Pharmacy Times
JANUARY 2, 2025
Over 70% of children and young people with long COVID reported improvements in their symptoms within 24 months of their initial positive SARS-CoV-2 test.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
JANUARY 2, 2025
The Phase III KOASTAL-1 study with Neumoras lead asset navacaprant failed to meet its primary and secondary endpoint.
Pharmaceutical Commerce
JANUARY 2, 2025
Lisa Arthurs, VP, trade, Two Labs, discusses a roundtable discussing women in trade as well as empowering future leaders.
Pharmaceutical Technology
JANUARY 2, 2025
MSD has received the UK MHRA approval for sotatercept, marketed as Winrevair, to treat PAH in the adult population.
Compounding Pharmacy of America
JANUARY 2, 2025
Learn about our compounding pharmacy services and shipping areas. Serving patients across the U.S. with custom medications tailored to your needs. The post Comprehensive Nationwide Compounding Pharmacy Services appeared first on Compounding Pharmacy of America.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
JANUARY 2, 2025
HUTCHMED (China) has entered into agreements to sell a 45% equity interest in Shanghai Hutchison Pharmaceuticals (SHPL)
PharmExec
JANUARY 2, 2025
Approval was based on results from the Phase III CheckMate-67T trial, which demonstrated non-inferior pharmacokinetics compared to intravenous Opvido.
Pharmaceutical Technology
JANUARY 2, 2025
Severe asthma is traditionally classified into either high or low T-helper cell type 2 (T2) subtypes.
PharmExec
JANUARY 2, 2025
Approval of Tevimbra was supported by the RATIONALE-305 Phase III trial, which demonstrated a significant overall survival benefit in patients with unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma.
Pharmaceutical Technology
JANUARY 2, 2025
Innovent and Roche have entered a partnership and exclusive licence agreement to accelerate the development of IBI3009.
Let's personalize your content